Patent intelligence · US
US 10000753
Age-related macular degeneration treatment
Age-related macular degeneration treatment
Patent details — US 10000753
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 19, 2018
- Expiration
- Jun 14, 2038
- Applicant
- Benitec Biopharma Limited
- Claims
- 23
- CPC classes
- A61P, A61P27/02, A61P9/00
Quick answer
US 10000753 (Age-related macular degeneration treatment) is held by Benitec Biopharma Limited. Status: granted. Granted Jun 19, 2018. Expires Jun 14, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Benitec Biopharma Limited
- Grant date
- Expiration
- Claims
- 23
- CPC classes
- A61P, A61P27/02, A61P9/00
More from Benitec Biopharma Limited
Related pharmaceutical patents in our USPTO index.
-
US 11932852
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 11535851
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
granted -
US 11234994
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 11142765
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted -
US 10898505
Reagents for treatment of hepatitis B virus (HBV) infection and use thereof
granted -
US 9518260
Pain treatment
granted -
US 9410154
HBV treatment
granted
Frequently asked questions
What is US patent 10000753?
US 10000753 (Age-related macular degeneration treatment) is held by Benitec Biopharma Limited. Status: granted. Granted Jun 19, 2018. Expires Jun 14, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10000753?
Benitec Biopharma Limited is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 13 pharmaceutical patents for this assignee.
When does US 10000753 expire?
Our index shows an expiration date of Jun 14, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.